Saint Alphonsus Cancer Care Center-Boise — Biomedical Watch V2

Essais liés8clinical trials

VilleBoiselocalisation

PaysUnited Stateslocalisation

SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT06337318

Ouvrir le site du centre

Essais cliniques associés

8

Molécule	Indication / population	Phase	NCT	Titre	Statut
Biospecimen Collection	Cancer	Phase 3	NCT06058377	Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer	RECRUITING
Azacitidine	Cancer	Phase 2	NCT05554406	Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)	RECRUITING
Acalabrutinib	Cancer	Phase 2	NCT04115631	A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lymphoma	ACTIVE_NOT_RECRUITING
Biospecimen Collection	Cancer	Phase 3	NCT06337318	Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma	RECRUITING
Biospecimen Collection	Cancer	Phase 3	NCT05256225	Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma	RECRUITING
Biospecimen Collection	Cancer	Phase 3	NCT04267848	Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])	RECRUITING
Biopsy Procedure	Cancer	Phase 2	NCT06126276	Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)	RECRUITING
Biospecimen Collection	Cancer	Phase 2/3	NCT06203600	Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial	RECRUITING